Surviving a Pandemic Without a Local Health Department
Published in Public Health
As schools, businesses, travel, and life as we knew it began to shut down in March of 2020, an often repeated phrase was “listen to your local health official.” Federal officials encouraged the public to tune into local leaders who could provide detailed accounts of what was happening in their local communities – how many new cases were there, how many people were hospitalized, how many ventilators were available, and how many people were dead (or dying). Similarly, as the country began to reopen during the summer of 2020, the public once again was told to “listen to your local health official” for instructions regarding how to safely navigate the world still swarming with COVID.
For those of us living in the 56 counties of Pennsylvania where there is no health department, these instructions to “listen to your local health official” made no sense. There was/is no local health official. There were local health clinics (staffed with nurses; not trained in public health) and public health professionals in Harrisburg, nearly 5 hours away, who were directing the public health response to the pandemic, but nothing about that felt relevant or local.
We were required to survive the pandemic without a local health official to listen to or lead us.
In Crawford County, home to Allegheny College and the research team that completed this study, a group of volunteers – a county commissioner, epidemiology professor, and retired science teacher – banded together to track cases, answer community questions, and establish a single online resource page (on Facebook because there was no money, resources, or expertise to build out a county health website). This band of volunteers had little (if any) contact with leaders in Harrisburg, but they shared information within the county and did their best to keep community members informed and calm through the initial crisis of the pandemic.
From 2020-2022 – we felt the void left by not having a local health department as a pandemic turned our worlds upside down. We had to source our own COVID tests, set up a contact tracing protocol (with only one individual in the community trained in public health), track our own data, establish relationships, and follow policies set by leaders who had never stepped foot in our community and who we did not know or trust.
It was not public health practice; it was survival.
In the years following, our research team started to ask questions that went beyond the pandemic – are counties with local health departments healthier? Do residents there have access to better healthcare? Do they get vaccinated more often?
These questions led to us completing an ecological epidemiological study where we assessed community health impacts, including obesity, infant mortality, smoking and vaping, percent of the population with health insurance, and youth suicidality, among others comparing counties with and without a local health department. We found that overall the counties in Pennsylvania without a local health department had poorer health outcomes compared to counties with a local health department after controlling for race, education, income, access to health insurance, and the urban–rural status of each county.
We believe there are significant benefits to having a local health department, and more than half of the population in Pennsylvania does not have access to those benefits due to the public health governance structure in the state. Policy changes are needed in Pennsylvania to establish and maintain a local health department in every community. Local health departments provide the foundation for creating healthy communties and they are needed throughout the state of Pennsylvania; not just in 11 of 67 counties.
Follow the Topic
-
Discover Public Health
This is an open access journal publishing research from all fields relevant to public health.
Related Collections
With Collections, you can get published faster and increase your visibility.
Public Health Strategies for the Management and Prevention of Tobacco Use and Emerging Tobacco Products
Tobacco use is considered as one of the hidden epidemics of the 21st century. Despite many efforts at policy level, tobacco use still remain one of the key factors for high morbidity and mortality worldwide. Globally around eight million people die due to tobacco consumption while daily people are diagnosed with lung cancer, COPD, cardiovascular diseases etc., with main factor being the tobacco consumption. Tobacco prevalence range between and within regions and countries as well as between male and female gender. Tobacco uses usually starts at adolescent and continue in the later life. At global level several initiatives have been undertaken with the WHO-FCTC being one of the most important. Additionally, at national levels countries have undertaken several initiatives but with not very successful results. On the other hand, tobacco industry is putting priority in the new products such as electronic cigarettes, heated tobacco etc. These products are not considered in many regions and countries as the normal tobacco products with their taxation, availability and use being different. To some extent, healthcare systems are not performing well in the management of the tobacco use which is considered a chronic condition. Availability of new medicaments and approaches and techniques is still a problem in many settings worldwide. Combination of tobacco use and other substances is also a critical issue.
This Collection aims to discuss key strategies for management of tobacco use and the new products at local, national, regional and global level as well as to propose key measures for healthcare personnel and policymakers in order to manage key challenges. Authors from different settings and different backgrounds are invited to submit their works to this Collection. Reviews and systematic analyses and meta- analyses, original articles, policy papers and case-studies are more than welcome to be submitted.
Research areas may include but are not limited to the following:
- Tobacco consumptions
- New tobacco products
- Prevention and management of tobacco use
- Substance use
- Technology and public health
- Prevention and health promotion
Keywords: tobacco, heated tobacco, public health, health policy, prevention and health promotion
This Collection supports and amplifies research related to SDG 3.
Publishing Model: Open Access
Deadline: Apr 30, 2026
Antimicrobial Resistance: The New Challenge to Global Health in a Post-Pandemic World
Antimicrobial resistance (AMR) is a seriously ongoing threat to global health, occurring when bacteria, fungi, viruses, and parasites evolve to resist the drugs designed to kill or block them. The COVID-19 pandemic has both directly and indirectly exacerbated the problem of AMR, as the overuse of antibiotics has accelerated the development of resistance in many pathogens. COVID-19 may have subsided, but AMR continues to pose a significant risk to the effectiveness of global healthcare systems, threatening to reverse decades of progress in combating infectious diseases. The interplay between population health and AMR has become increasingly critical as healthcare practices have shifted in response to the pandemic. Understanding this relationship is essential for developing effective strategies to mitigate the impact of AMR on population health in a post-COVID context.
The motivation for launching this Collection arises from the urgent need to address the rising tide of AMR as healthcare systems grapple with the long-term effects of the pandemic. Increased antibiotic use during COVID-19 treatment, changes in healthcare access, and disruptions in public health interventions have all contributed to an environment where AMR can thrive. Moreover, the pandemic has highlighted the importance of a multidisciplinary approach to tackling AMR, involving epidemiology, policymaking, and community health initiatives. This Collection aims to provide a platform for researchers and practitioners to share insights and findings that can inform future strategies to combat AMR while considering the broader implications for population health.
This Collection aims to highlight the multifaceted nature of AMR in a post-pandemic environment. We solicit articles that investigate the particular issues provided by the pandemic in terms of AMR development and containment, examine the impact of AMR on many sectors of healthcare, and propose novel strategies to minimize resistance propagation. Submissions may include original research, policy assessments, program evaluations, and comments on the following major areas:
• Epidemiology and trends of AMR post-pandemic
• Impact of COVID-19 on antibiotic usage
• Surveillance strategies for AMR
• AMR and stewardship
• Prevention and control measures to limit AMR spread
• Policies and programs to promote antibiotic stewardship
• Economic and social implications of AMR
• Global collaboration and initiatives to tackle AMR
By addressing these critical issues, this Collection aims to provide a comprehensive understanding of the emerging challenges in antimicrobial resistance in a post-pandemic world and to promote effective strategies to preserve the power of our current antimicrobials.
Keywords: antimicrobial resistance; COVID-19; antibiotics; global health; infectious diseases; public health; policy; prevention
This Collection supports and amplifies research related to SDG 3.
Publishing Model: Open Access
Deadline: Jun 30, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in